Rangwala, R
The blood concentrations of acylcarnitines with saturated long-chain fatty acids were 0.09 0.05 mol/L, 1.02 0.32 mol/L, 0.39 0.14 mol/L, 0.01 .007 mol/L, 0.001 0.002 mol/L and 0.001 0.003 mol/L for myristoylcarnitine (C14), palmitoylcarnitine (C16), stearoylcarnitine (C18), hydroxymyristoylcarnitine (C14OH), hydroxypalmitoylcarnitine (C16OH) and 3-hydroxystearoylcarnitine (C18-OH), respectively, in the patients group
NADP+, nicotinamide adenine dinucleotide phosphate
The 60 mg dose in real life reduced hypoglycaemic events by up to 60% without the appearance of hyperglycaemia49
Most of the glycemic, lipid, and renal parameters remained stable during both treatments, but HOMA-IR significantly decreased after 6-month ALC and placebo in the short-term and in the long-term statin stratum, respectively
Step 1 - Online health questionnaire